Intercept Pharmaceuticals Inc

Intercept Pharmaceuticals is a biopharmaceutical company focused on developing and delivering novel medicines for individuals living with rare and serious liver diseases. Headquartered in Morristown, New Jersey, the company is committed to addressing unmet medical needs through its research and development efforts, including the only FDA-approved second-line treatment for primary biliary cholangitis.